The Patent Finder

LBL Biotechnology Inc.

Also on record
Records under this name other than the patents LBL Biotechnology Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.

Showing 1 to 4 of 4 · Back to LBL Biotechnology Inc.

PatentTitleStatus Expires Confidence
US 8,377,441Treating Breast Cancer with Anti-IL-19 Antibody
Lapsed on the fee record
Ended Feb 19, 2025 · High confidence
Lapsed on the fee recordEnded Feb 19, 2025High confidence
US 8,206,712Use of ANTI-IL-20 Antibody for Treating Rheumatoid Arthritis
Lapsed on the fee record
Ended Jun 26, 2024 · High confidence
Lapsed on the fee recordEnded Jun 26, 2024High confidence
US 7,435,800Antibodies to INTERLEUKIN-20 and Method for Inhibiting INTERLEUKIN-20 Induced Cell Proliferation
Term ended
Term ended Feb 29, 2024 · Medium confidence
Term endedTerm ended Feb 29, 2024Medium confidence
US 7,786,274ANTI-IL-20 Antibody and Its Use in Treating IL-20 Associated Inflammatory Diseases
Lapsed on the fee record
Ended Aug 31, 2022 · Medium confidence
Lapsed on the fee recordEnded Aug 31, 2022Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited